Clinical Trial Update: The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease

View source ↗

Summary

The document announces a clinical study of synaptic plasticity-based Lencanumab for early Alzheimer's disease and notes that the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lencanumab

Snippet

Sponsor: Cuibai Wei，Clinical Professor | Conditions: Alzheimer's Disease, Lecanemab | Status: RECRUITING